Back to results
US 2022/0054664 A1Published application
Pharmacokinetic enhancements of bifunctional chelates and uses thereof
AssigneeCentre for Probe Development and Commercialization
InventorsEric Steven Burak, Stuart James Mahoney, Ryan Wayne Simms, John Fitzmaurice Valliant, Alla Darwish
Life of this patent
Estimating the term…
Abstract
The present invention relates to conjugates including a chelating moiety of a metal complex thereof and a therapeutic or targeting moiety, methods for their production, and uses thereof.
Claims16
A method of radiation treatment planning or radiation treatment, wherein the method comprises administering to a subject in need thereof an effective amount of a compound having the structure of Formula I:
- A-L1-(L2)n-B Formula I
- wherein A is chelating moiety or a metal complex thereof;
- L1 is optionally substituted C1-C6 alkyl, substituted C1-C6 heteroalkyl, substituted aryl or heteroaryl;
- B is a is a therapeutic moiety, a targeting moiety, or cross-linking group,
- or a pharmaceutically acceptable salt thereof;
- n is 1-5;
- each L2, independently, has the structure:
- (—X1-L3-Z1—) Formula II
- wherein is X1 is C═O(NR1), C═S(NR1), OC═O(NR1), NR1C═O(O), NR1C═O(NR1), —CH2PhC═O(NR1), —CH2Ph(NH)C═S(NR1), O, NR1 and R1 is H or optionally substituted C1-C6 alkyl or optionally substituted C1-C6 heteroalkyl, substituted aryl or heteroaryl;
- L3 is optionally substituted C1-C50 alkyl or optionally substituted C1-C50 heteroalkyl or C5-C20 polyethylene glycol;
- Z1 is CH2, C═O, C═S, OC═O, NR1C═O, NR1;
- and
- R1 is a hydrogen or optionally substituted C1-C6 alkyl, pyrrolidine-2,5-dione.
10 more elements
Dependencies are inferred from the claim text.